We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $168M
1-Year Est. Return 60.36%
This Fund
S&P 500
This Quarter Est. Return
+20.64%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$265M
AUM Growth
+$27M
Cap. Flow
-$20.6M
Cap. Flow %
-7.77%
Top 10 Hldgs %
60.48%
Holding
196
New
11
Increased
11
Reduced
19
Closed
23

Top Buys

Rank Stock Value
1
OABI icon
OmniAb
OABI
+$6.67M
2
CSX icon
CSX Corp
CSX
+$2.11M
3
CLMT icon
Calumet Specialty Products
CLMT
+$1.85M
4
SNY icon
Sanofi
SNY
+$1.58M
5
ARDX icon
Ardelyx
ARDX
+$1.44M

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$4.51M
2
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
+$3.08M
3
GLHAW
Glass Houses Acquisition Corp. Warrant
GLHAW
+$2.88M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$2.74M
5
PFE icon
Pfizer
PFE
+$2.35M

Sector Composition

Rank Sector Weight
1 Materials 29.69%
2 Healthcare 28.82%
3 Financials 9.61%
4 Consumer Staples 6.03%
5 Real Estate 5.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRTX icon
26
Vertex Pharmaceuticals
VRTX
$123B
$2.31M 0.87%
8,000
-9,000
-53% -$2.74M
AVDL
27
DELISTED
Avadel Pharmaceuticals
AVDL
$2.22M 0.84%
310,251
-80,610
-21% -$565K
CSX icon
28
CSX Corp
CSX
$94.3B
$2.17M 0.82%
+70,000
New +$2.11M
GSK icon
29
GSK
GSK
$104B
$2.11M 0.8%
60,000
+20,000
+50% +$666K
TWLVW
30
DELISTED
Twelve Seas Investment Company II Warrant
TWLVW
$1.92M 0.72%
166,666
– –
EXE
31
Expand Energy Corp
EXE
$21.1B
$1.89M 0.71%
20,000
– –
CVE icon
32
Cenovus Energy
CVE
$52.1B
$1.84M 0.7%
95,000
– –
OVV icon
33
Ovintiv
OVV
$16.2B
$1.77M 0.67%
35,000
– –
AB icon
34
AllianceBernstein
AB
$3.54B
$1.74M 0.66%
50,500
– –
KAIRW
35
DELISTED
Kairos Acquisition Corp. Warrant
KAIRW
$1.6M 0.61%
139,278
– –
GMED icon
36
Globus Medical
GMED
$10.5B
$1.55M 0.58%
20,831
+2,000
+11% +$136K
MOS icon
37
The Mosaic Company
MOS
$7.03B
$1.53M 0.58%
35,000
– –
BIP icon
38
Brookfield Infrastructure Partners
BIP
$18.1B
$1.4M 0.53%
45,000
– –
BRIVW
39
DELISTED
B. Riley Principal 250 Merger Corp. Warrant
BRIVW
$1.34M 0.51%
116,666
– –
FIP icon
40
FTAI Infrastructure
FIP
$492M
$1.25M 0.47%
425,000
– –
PMGMW
41
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
$1.15M 0.43%
100,000
– –
MCRB icon
42
Seres Therapeutics
MCRB
$51.6M
$1.12M 0.42%
10,005
+4,505
+82% +$604K
CHRS icon
43
Coherus Oncology
CHRS
$216M
$1.02M 0.38%
128,517
-71,483
-36% -$550K
RHP icon
44
Ryman Hospitality Properties
RHP
$7.99B
$1.01M 0.38%
12,400
-12,000
-49% -$1.03M
PSTX
45
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$895K 0.34%
168,839
+17,553
+12% +$80.2K
LOKM.WS
46
DELISTED
Live Oak Mobility Acquisition Corp. Warrants, exercisable for one share of Class A common stock at an exercise price of $11.50 per share
LOKM.WS
$828K 0.31%
72,030
– –
KMB icon
47
Kimberly-Clark
KMB
$36B
$815K 0.31%
6,000
– –
ABBV icon
48
AbbVie
ABBV
$450B
$814K 0.31%
5,037
-15,000
-75% -$2.3M
CCOI icon
49
Cogent Communications
CCOI
$549M
$799K 0.3%
14,000
– –
DD icon
50
DuPont de Nemours
DD
$18.3B
$764K 0.29%
8,872
– –
1
2
3 4 5

Similar funds

DI
Disciplined Investors Waco, Texas $168M AUM 23.6% 1-Year Est. Return
WFS
Widmann Financial Services Bowie, Maryland $168M AUM 24.36% 1-Year Est. Return
CCG
Catalina Capital Group Torrance, California $168M AUM 16.69% 1-Year Est. Return
7CM
7G Capital Management New York $168M AUM 45.68% 1-Year Est. Return
TT
TI-Trust Quincy, Illinois $168M AUM 24.32% 1-Year Est. Return
MAG
Meadowbrook Advisors Group Bedminster, New Jersey $168M AUM
PFA
Presper Financial Architects Akron, Ohio $168M AUM 12.94% 1-Year Est. Return
CW
Code Waechter Tampa, Florida $168M AUM 15.56% 1-Year Est. Return

David M. Knott Jr's Q4 2022 Portfolio in Review

As of Q4 2022, David M. Knott Jr held 196 positions worth $265M, up 11% from $238M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

David M. Knott Jr withdrew a net $20.6M in Q4 2022, closing 23 positions and reducing 19 holdings. Its most notable exit was Eiger BioPharmaceuticals, Inc., an estimated $3.08M position sold in full.

By sector, the portfolio is most concentrated in Materials at 30% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

Against the trend, David M. Knott Jr opened a new position in OmniAb worth $4.58M.

  • David M. Knott Jr's largest Q4 2022 buy was OmniAb: 1,270,939 shares worth $4.58M.
  • David M. Knott Jr added most to Calumet Specialty Products in Q4 2022, an estimated $1.85M increase.
  • David M. Knott Jr's biggest Q4 2022 reduction was Ligand Pharmaceuticals, cutting an estimated $4.51M.
  • David M. Knott Jr fully exited Eiger BioPharmaceuticals, Inc. in Q4 2022, selling an estimated $3.08M.
  • David M. Knott Jr's ten largest holdings make up 60% of its $265M portfolio in Q4 2022.
  • David M. Knott Jr opened 11 new positions and closed 23 in Q4 2022.
  • David M. Knott Jr's portfolio value rose 11% quarter-over-quarter to $265M.

Based on David M. Knott Jr's 13F filing for Q4 2022, filed 13 Feb 2023.